↓ Skip to main content

Pharmacologic Therapy of Ocular Disease

Overview of attention for book
Attention for Chapter 26: Anti-Infective and Anti-Inflammatory Pharmacotherapies
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Anti-Infective and Anti-Inflammatory Pharmacotherapies
Chapter number 26
Book title
Pharmacologic Therapy of Ocular Disease
Published in
Handbook of experimental pharmacology, April 2017
DOI 10.1007/164_2017_26
Pubmed ID
Book ISBNs
978-3-31-958288-7, 978-3-31-958290-0
Authors

Rosenblatt, Mark I., Mark I. Rosenblatt

Abstract

Ocular infection and inflammation are common and are associated with myriad ocular conditions ranging from mild disease to blinding conditions. There are numerous anti-invectives with spectra against inciting pathogens. Given the potential for ocular infections to rapidly progress initial broad spectrum therapy is usually required, with therapy tailored as microbiological identification and sensitivities become available. The emergence of antibiotic resistance has become a major health problem. Anti-inflammatory therapy can be institutes to prevent ocular symptoms and end-organ damage. A therapy should be selected which is potent enough to interrupt the inflammatory cascades in play, but which avoids potential side effects. Glucocorticoids, NSAIDs, and biological agents may be used singularly or in combination. New drug delivery devices may allow for better local treatment of chronic ocular inflammation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 25%
Student > Doctoral Student 2 10%
Unspecified 1 5%
Lecturer 1 5%
Other 1 5%
Other 5 25%
Unknown 5 25%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 15%
Medicine and Dentistry 3 15%
Nursing and Health Professions 2 10%
Chemistry 2 10%
Agricultural and Biological Sciences 1 5%
Other 2 10%
Unknown 7 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2017.
All research outputs
#15,404,310
of 22,965,074 outputs
Outputs from Handbook of experimental pharmacology
#397
of 646 outputs
Outputs of similar age
#192,871
of 309,525 outputs
Outputs of similar age from Handbook of experimental pharmacology
#4
of 7 outputs
Altmetric has tracked 22,965,074 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 646 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,525 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.